Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosis
about
Evolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapyVirulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpCMycobacterium tuberculosis metabolismDeficiency of the novel exopolyphosphatase Rv1026/PPX2 leads to metabolic downshift and altered cell wall permeability in Mycobacterium tuberculosisRevisiting Protocols for the NMR Analysis of Bacterial MetabolomesAnalysis of serum metabolic profile by ultra-performance liquid chromatography-mass spectrometry for biomarkers discovery: application in a pilot study to discriminate patients with tuberculosis.The polyphosphate kinase gene ppk2 is required for Mycobacterium tuberculosis inorganic polyphosphate regulation and virulenceMycobacteriophage SWU1 gp39 can potentiate multiple antibiotics against Mycobacterium via altering the cell wall permeability.Rifampin Resistance Mutations Are Associated with Broad Chemical Remodeling of Mycobacterium tuberculosis.Comparative Proteomic Analyses of Avirulent, Virulent, and Clinical Strains of Mycobacterium tuberculosis Identify Strain-specific PatternsComparing isogenic strains of Beijing genotype Mycobacterium tuberculosis after acquisition of Isoniazid resistance: A proteomics approach.Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis.The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?The use of functional genomics in conjunction with metabolomics for Mycobacterium tuberculosis research.Neglected diseases prioritized in Brazil under the perspective of metabolomics: A review.Metabolomics: Applications and Promise in Mycobacterial Disease.Survival proteomes: the emerging proteotype of antimicrobial resistance.The Cell Wall Lipid PDIM Contributes to Phagosomal Escape and Host Cell Exit of Mycobacterium tuberculosis.In vitro and in vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D.New insights into the survival mechanisms of rifampicin-resistant Mycobacterium tuberculosis.Whole transcriptomic and proteomic analyses of an isogenic M. tuberculosis clinical strain with a naturally occurring 15 Kb genomic deletion.HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells.Comparative Proteomic Analysis of Mycobacterium tuberculosis Lineage 7 and Lineage 4 Strains Reveals Differentially Abundant Proteins Linked to Slow Growth and Virulence.Strain Diversity and the Evolution of Antibiotic Resistance.Altered Mycobacterium tuberculosis Cell Wall Metabolism and Physiology Associated With RpoB Mutation H526D.On the mechanism of phosphoenolpyruvate synthetase (PEPs) and its inhibition by sodium fluoride: potential magnesium and aluminum fluoride complexes of phosphoryl transfer.Biochemical Characterization of Isoniazid-resistant Can the Analysis of Clonal Strains Reveal Novel Targetable Pathways?Machine learning and structural analysis of Mycobacterium tuberculosis pan-genome identifies genetic signatures of antibiotic resistance
P2860
Q27016579-CF1548B9-9BED-4136-93C9-8AC6D47807B6Q28554450-97A664B5-1D88-465C-8E99-778107B9F27CQ35245286-F09A6A33-AF1F-4558-915D-540549B85402Q35677431-74CD6915-1332-4E33-AD5B-65A138A4ED63Q35733896-E32BD7B0-A239-42BE-944A-A3208AADE3A5Q36816275-08680E4F-9FB1-44DD-B902-5CE7337B95C0Q36873784-34373AF7-2ED1-45F9-8D1A-3DF6B481DDF9Q37044373-289E1315-FDAB-458F-8FF3-D74B58AB2D94Q37065759-071897CC-FC8B-4A10-84F5-C0FF7A126940Q37065764-C5EDAD45-90AB-4F3A-B3E2-9F7467A93BC5Q37357279-B5D923E7-5E9C-4C38-B114-7F2DBFFA93D3Q37460800-1099C937-8D0E-4B10-8D50-66A60636C74BQ37683485-BF527903-351C-4BA6-A296-98A7CBE7D989Q38207579-7180AAB8-943A-49DF-AC0B-A4E7EE351945Q38533526-241F254E-FC0D-4401-BC0E-F3B35618FA48Q38551411-A3114E4A-F462-40C2-AEA6-DE402ED3801EQ38704552-04BA1664-A445-4B20-BBB3-3A60925F3C78Q38713208-CB899960-2311-4F6C-AEB2-6E9663CB046AQ38739681-87F5E2CC-C413-44F5-9FB7-AAA874C5716AQ38930894-23719CB0-5E2F-43FE-991D-970AB9968AA4Q40145327-C2349F22-F875-4937-83D4-F6EBA56CC75FQ40147542-BABC3EEA-3133-403E-BD36-8AAC47E351C7Q40201453-F4DAF6E2-DCA7-4736-9B63-9042FD3041CEQ47851713-AEC25E6A-7646-46B0-9A6C-E65797CFDC9CQ53698585-38DDB832-D586-437F-AD7C-4D893452606AQ54288705-4924EE9F-C7CD-4901-B0BB-6905C28936FBQ57217262-3D050D22-C032-4AAB-A992-97A1F59C6A97Q58547235-2D12EA71-BC8A-4CD8-9651-9E74899C3244
P2860
Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Upregulation of the phthiocero ...... ant Mycobacterium tuberculosis
@ast
Upregulation of the phthiocero ...... ant Mycobacterium tuberculosis
@en
type
label
Upregulation of the phthiocero ...... ant Mycobacterium tuberculosis
@ast
Upregulation of the phthiocero ...... ant Mycobacterium tuberculosis
@en
prefLabel
Upregulation of the phthiocero ...... ant Mycobacterium tuberculosis
@ast
Upregulation of the phthiocero ...... ant Mycobacterium tuberculosis
@en
P2093
P2860
P50
P356
P1476
Upregulation of the phthiocero ...... ant Mycobacterium tuberculosis
@en
P2093
Carolina Mehaffy
Corey Broeckling
Desmond S Lun
Drew Weissman
Marcos Burgos
Petros C Karakousis
P2860
P304
P356
10.1128/JB.01013-12
P407
P577
2012-09-21T00:00:00Z